Federal False Claims Act 2022 Marked Significant Appellate Activity
The federal False Claims Act FCA remained in flux in 2022, marked by significant activity at the appellate level. DOJ’s enforcement of the FCA remained robust, headlined by a $900 million settlement with Biogen, Inc. arising out of an Anti-Kickback Statute violation.